A recent study indicates that a U.S. ban on the use of tanning beds among minors would prevent thousands of cases of melanoma in adolescents and would save millions of dollars in healthcare costs. The findings are published early online in CANCER, a peer-reviewed journal of the American Cancer Society.
Indoor tanning has been linked to an increased risk of melanoma, with the highest risk in those who start using tanning beds at a young age. Unfortunately, the use of tanning beds is a common practice among U.S. adolescents.
Despite the risk of indoor tanning, only a handful of countries have implemented policies to ban tanning beds. Such bans have the potential to save lives and treatment-related costs but come with costs of policy implementation and enforcement, as well as lost revenue to the tanning industry.
To consider both the benefits and costs of a ban, investigators modeled the life course of the U.S. population aged between 14 and 17 years and compared two situations: ban versus no ban.
The team's simulations revealed that fully adhering to a ban would prevent 15,101 melanoma cases and 3,299 melanoma recurrences among 17.1 million minors, saving $61 in direct and indirect healthcare costs per minor. When including intervention costs and economic losses to the tanning bed industry, banning still saved $12 per minor and a total of $205.4 million over the lifetimes of 17.1 million minors.
"A ban on tanning bed use in minors is not universal in Canada and the U.S. In Brazil and Australia there is a total ban not just in minors, while in Austria, Belgium, France, Germany, Portugal, Spain, and the United Kingdom, national bans exist for those under the age of 18," said lead author Antoine Eskander, MD, ScM, FRCSC, of the University of Toronto and Sunnybrook Health Sciences Centre.
"This work demonstrates the societal implications of a ban in North America and points to the value of this policy, which should be considered by state, provincial, and national/federal governments," added co-senior author David Goldstein, MD, MSc, FRCSC, of the University of Toronto and Princess Margaret Cancer Centre.
NOTE: The information contained in this release is protected by copyright. Please include journal attribution in all coverage. A free abstract of this article will be available via the Cancer News Room upon online publication. For more information or to obtain a PDF of any study, please contact:
Dawn Peters +1 781-388-8408 (US)
Follow us on Twitter @WileyNews
Full Citation: "To ban or not to ban tanning bed use for minors: A cost effectiveness analysis from multiple U.S. perspectives for invasive melanoma." Antoine Eskander, Kathryn E. Marqueen, Heather A. Osborn, Anthony M. Joshua, Teresa M. Petrella, John R. de Almeida, David P. Goldstein, and Bart S. Ferket. CANCER; Published Online: April 12, 2021 (DOI: 10.1002/cncr.33499).
URL Upon Publication: http://doi.
About the Journal
CANCER is a peer-reviewed publication of the American Cancer Society integrating scientific information from worldwide sources for all oncologic specialties. The objective of CANCER is to provide an interdisciplinary forum for the exchange of information among oncologic disciplines concerned with the etiology, course, and treatment of human cancer. CANCER is published on behalf of the American Cancer Society by Wiley and can be accessed online.
Follow us on Twitter @JournalCancer
Wiley drives the world forward with research and education. Through publishing, platforms and services, we help students, researchers, universities, and corporations to achieve their goals in an ever-changing world. For more than 200 years, we have delivered consistent performance to all of our stakeholders. The Company's website can be accessed at http://www.